Boundless Bio, Inc. Share Price
BOLDBoundless Bio, Inc. Stock Performance
Open $1.19 | Prev. Close $1.19 | Circuit Range N/A |
Day Range $1.19 - $1.19 | Year Range $1.01 - $2.77 | Volume 140 |
Average Traded $1.19 |
Boundless Bio, Inc. Share Price Chart
About Boundless Bio, Inc.
Boundless Bio, Inc., a clinical-stage oncology company, develops cancer therapeutics to address the unmet need of patients with oncogene amplified tumors by interrogating extrachromosomal DNA (ecDNA). The company's lead product candidate is BBI-355, an ecDNA-directed therapeutic candidate and oral inhibitor of checkpoint kinase 1 that is in Phase 1/2 clinical trial in patients with oncogene amplified cancers. It also develops BBI-098, a picomolar biochemical inhibition of checkpoint kinase 1 demonstrating central nervous system penetrance in preclinical models. In addition, the company offers ECHO, an ecDNA harboring oncogenes diagnostic test to detect ecDNA in patient tumor specimens; and Spyglass platform, a platform used to identify druggable targets in oncogene amplified cancers. The company was formerly known as Pretzel Therapeutics, Inc. and changed its name to Boundless Bio, Inc. in July 2019. Boundless Bio, Inc. was incorporated in 2018 and is headquartered in San Diego, California.
Boundless Bio, Inc. Historical Data
| Day | Open | Close | Change % |
|---|---|---|---|
02-Jan-26 | $1.22 | $1.21 | +1.68% |
31-Dec-25 | $1.20 | $1.19 | -1.65% |
29-Dec-25 | $1.21 | $1.21 | -3.20% |
19-Dec-25 | $1.27 | $1.25 | -2.34% |
18-Dec-25 | $1.16 | $1.28 | +1.59% |
17-Dec-25 | $1.14 | $1.26 | +10.53% |
15-Dec-25 | $1.14 | $1.14 | -2.98% |
FAQs on Boundless Bio, Inc. Share Price
Can I buy Boundless Bio, Inc. shares in India?
What is the share price of Boundless Bio, Inc.?
What is the 5 year returns of Boundless Bio, Inc.?
What are the high & low stock price of Boundless Bio, Inc. today?
What is the 52-week high and low of Boundless Bio, Inc. stock?